| scholarly article | Q13442814 |
| P50 | author | Cornelia C. Bergmann | Q55426323 |
| Richard M Ransohoff | Q87833085 | ||
| Stephen A Stohlman | Q117769757 | ||
| Roscoe A Atkinson | Q117769761 | ||
| P2093 | author name string | Carine Savarin | |
| P2860 | cites work | CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis | Q27486590 |
| Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis | Q27486985 | ||
| Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions | Q28203732 | ||
| Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier | Q28291314 | ||
| Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis | Q28755978 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| The many roles of chemokines and chemokine receptors in inflammation | Q29618880 | ||
| A protective role for ELR+ chemokines during acute viral encephalomyelitis | Q33515263 | ||
| Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. | Q33724251 | ||
| The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system | Q33943410 | ||
| Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. | Q34132328 | ||
| Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. | Q34264593 | ||
| Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages | Q34385281 | ||
| Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. | Q34413750 | ||
| Matrix metalloproteinases in neuroinflammation | Q34803809 | ||
| Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis | Q35788031 | ||
| Extracellular proteases in atherosclerosis and restenosis. | Q36085385 | ||
| The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms | Q36205278 | ||
| Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis | Q36326348 | ||
| Coronavirus infection of the central nervous system: host-virus stand-off | Q36369843 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. | Q36423925 | ||
| Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system. | Q36434847 | ||
| CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. | Q36483798 | ||
| Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases | Q36588762 | ||
| Inflammatory cell migration into the central nervous system: a few new twists on an old tale | Q36771887 | ||
| Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies | Q36863593 | ||
| Chemokine action in the nervous system | Q37323999 | ||
| Perivascular spaces and the two steps to neuroinflammation | Q37329042 | ||
| Involvement of ROS in BBB dysfunction | Q37400756 | ||
| In vivo properties of monocyte chemoattractant protein-1. | Q41640087 | ||
| Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. | Q41689082 | ||
| Matrix metalloproteinases and diseases of the CNS. | Q41719486 | ||
| Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis | Q41895463 | ||
| Blood-brain barrier disruption in simian immunodeficiency virus encephalitis | Q42495207 | ||
| CTL effector function within the central nervous system requires CD4+ T cells | Q45229138 | ||
| CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. | Q45420445 | ||
| Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. | Q45952711 | ||
| Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis | Q46118557 | ||
| IFN-gamma is required for viral clearance from central nervous system oligodendroglia | Q46323621 | ||
| Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation | Q46464036 | ||
| Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. | Q47914837 | ||
| What is the blood-brain barrier (not)? | Q48350383 | ||
| What is immune privilege (not)? | Q48356667 | ||
| CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis | Q48365016 | ||
| Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system | Q48379700 | ||
| Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain | Q48430048 | ||
| Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis | Q57042059 | ||
| Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice | Q57042734 | ||
| Astrocytes induce blood–brain barrier properties in endothelial cells | Q57318253 | ||
| Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions | Q59070288 | ||
| Differential roles of CCL2 and CCR2 in host defense to coronavirus infection | Q80942488 | ||
| Maturation and localization of macrophages and microglia during infection with a neurotropic murine coronavirus | Q81438898 | ||
| P433 | issue | 10 | |
| P921 | main subject | viral encephalitis | Q3053951 |
| neuroglia | Q177105 | ||
| cell migration | Q189092 | ||
| P304 | page(s) | 4878-4888 | |
| P577 | publication date | 2010-03-03 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis | |
| P478 | volume | 84 |
| Q36667911 | Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis |
| Q36216207 | Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice |
| Q35185219 | CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression |
| Q35826089 | CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis |
| Q30541389 | CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q35947646 | CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis |
| Q59354509 | Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease |
| Q27008829 | Clearance of virus infection from the CNS |
| Q35075777 | Comparison of the neuropathology induced by two West Nile virus strains |
| Q30530989 | Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation |
| Q37270693 | Differential Regulation of Self-reactive CD4+ T Cells in Cervical Lymph Nodes and Central Nervous System during Viral Encephalomyelitis |
| Q30585165 | Differential roles of microglia and monocytes in the inflamed central nervous system |
| Q55376062 | Distinct Gene Profiles of Bone Marrow-Derived Macrophages and Microglia During Neurotropic Coronavirus-Induced Demyelination. |
| Q42679281 | Downregulation of CCL2 induced by the upregulation of microRNA-206 is associated with the severity of HEV71 encephalitis |
| Q33767086 | ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease |
| Q36535632 | Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis. |
| Q34742821 | Factors supporting intrathecal humoral responses following viral encephalomyelitis. |
| Q36126949 | Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection |
| Q36164180 | IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils |
| Q35121857 | IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis |
| Q37228165 | IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis |
| Q37547551 | Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages |
| Q36548152 | Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination. |
| Q26861256 | Inflammatory monocytes and the pathogenesis of viral encephalitis |
| Q36012587 | Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. |
| Q36884649 | Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. |
| Q36584434 | Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination |
| Q37342611 | MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis. |
| Q35216111 | MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. |
| Q35973650 | Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis. |
| Q35003502 | Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum. |
| Q38861938 | Neutrophils and viral-induced neurologic disease |
| Q33606456 | PKR mediated regulation of inflammation and IL-10 during viral encephalomyelitis |
| Q54979894 | Phosphatidyl-Inositol-3 Kinase Inhibitors Regulate Peptidoglycan-Induced Myeloid Leukocyte Recruitment, Inflammation, and Neurotoxicity in Mouse Brain. |
| Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
| Q34512363 | Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies |
| Q40345242 | Sequential transmigration of polymorphonuclear cells and naive CD3+ T lymphocytes across the blood-cerebrospinal-fluid barrier in vitro following infection with Echovirus 30. |
| Q36468266 | The chemokine receptor CXCR2 and coronavirus-induced neurologic disease |
| Q38120697 | The neuroimmune response to West Nile virus |
| Q36607168 | Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection |
| Q35261421 | West Nile virus: immunity and pathogenesis |
Search more.